{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:05:14Z","timestamp":1792098314425,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clgc.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T23:17:26Z","timestamp":1530832646000},"page":"445-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non\u2013muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"Mihai Dorin","family":"Vartolomei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-4358","authenticated-orcid":false,"given":"Francesco","family":"Cantiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7807-1229","authenticated-orcid":false,"given":"Giuseppe","family":"Lucarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savino","family":"Di Stasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Hurle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Guazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Maria","family":"Busetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"De Berardinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Damiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisto","family":"Perdona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Verze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Borghesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Brunocilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto L.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Bove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-7968","authenticated-orcid":false,"given":"Estevao","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7045-7725","authenticated-orcid":false,"given":"Riccardo","family":"Autorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Crisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdal Rahman","family":"Abu Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Serretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Ivan","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Morgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4296-429X","authenticated-orcid":false,"given":"Daniela","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Musi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"de Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mirone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2018.07.003_bib1","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2018.07.003_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eururo.2012.09.057","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers","volume":"63","author":"Kamat","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00345-011-0709-9","article-title":"Impact of gender on bladder cancer incidence, staging, and prognosis","volume":"29","author":"Fajkovic","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/bjc.2013.372","article-title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","volume":"109","author":"Xylinas","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2018.07.003_bib8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.urology.2007.10.041","article-title":"Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy","volume":"71","author":"Gupta","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2018.07.003_bib9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eururo.2015.01.032","article-title":"Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature","volume":"68","author":"Kluth","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2009.09.024","article-title":"Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort","volume":"57","author":"Fritsche","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib11","doi-asserted-by":"crossref","first-page":"15114","DOI":"10.18632\/oncotarget.14750","article-title":"SETD6 regulates NF-\u03baB signaling in urothelial cell survival: implications for bladder cancer","volume":"8","author":"Mukherjee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clgc.2018.07.003_bib12","doi-asserted-by":"crossref","first-page":"62681","DOI":"10.18632\/oncotarget.17467","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clgc.2018.07.003_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00345-016-1848-9","article-title":"Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy","volume":"35","author":"Vartolomei","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib14","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00345-018-2235-5","article-title":"Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients","volume":"36","author":"Vartolomei","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10147-017-1171-5","article-title":"The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis","volume":"22","author":"Tang","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clgc.2018.07.003_bib16","first-page":"181","article-title":"Easily available blood test neutrophil-to-lymphocyte ratio predicts progression in high-risk non-muscle invasive bladder cancer","volume":"25","author":"Martha","year":"2017","journal-title":"Rev Romana Med Lab"},{"key":"10.1016\/j.clgc.2018.07.003_bib17","doi-asserted-by":"crossref","first-page":"E126","DOI":"10.5489\/cuaj.2523","article-title":"Neutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer","volume":"9","author":"Ozyalvacli","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.clgc.2018.07.003_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756287211398255","article-title":"Role of inflammation in bladder function and interstitial cystitis","volume":"3","author":"Grover","year":"2011","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"issue":"Suppl 3","key":"10.1016\/j.clgc.2018.07.003_bib20","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/314064","article-title":"Efficacy and safety of bacille Calmette-Gu\u00e9rin immunotherapy in superficial bladder cancer","volume":"31","author":"Lamm","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clgc.2018.07.003_bib21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.eururo.2011.12.055","article-title":"Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma","volume":"61","author":"Rink","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1590\/S1677-5538.IBJU.2015.0243","article-title":"Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study","volume":"42","author":"Favilla","year":"2016","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib23","doi-asserted-by":"crossref","first-page":"e755","DOI":"10.1016\/j.clgc.2017.03.007","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in primary non-muscle-invasive bladder cancer","volume":"15","author":"D\u2019Andrea","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2018.07.003_bib24","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/bju.12403","article-title":"Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis","volume":"113","author":"Breau","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2018.07.003_bib25","doi-asserted-by":"crossref","first-page":"483.e17","DOI":"10.1016\/j.urolonc.2016.05.013","article-title":"Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer","volume":"34","author":"Mbeutcha","year":"2016","journal-title":"Urol Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.clgc.2018.07.003_bib26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1245\/s10434-016-5578-4","article-title":"The preoperative neutrophil-to-lymphocyte ratio is a novel biomarker for predicting worse clinical outcomes in non-muscle invasive bladder cancer patients with a previous history of smoking","volume":"23","author":"Ogihara","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clgc.2018.07.003_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.urolonc.2014.06.010","article-title":"Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer","volume":"33","author":"Mano","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2018.07.003_bib28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/cncr.30422","article-title":"Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: assessing prognostic and predictive value in SWOG 87 10","volume":"123","author":"Ojerholm","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2018.07.003_bib29","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.18632\/oncotarget.14179","article-title":"Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clgc.2018.07.003_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.05.014","article-title":"Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): a systematic review and meta-analysis","author":"Vartolomei","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2018.07.003_bib31","doi-asserted-by":"crossref","first-page":"1506824","DOI":"10.1155\/2017\/1506824","article-title":"Dynamics of neutrophils-to-lymphocyte ratio predict outcomes of PD-1\/PD-L1 blockade","volume":"2017","author":"Moschetta","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.clgc.2018.07.003_bib32","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2147\/OTT.S153290","article-title":"Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis","volume":"11","author":"Sacdalan","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.clgc.2018.07.003_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40425-018-0315-0","article-title":"Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma","volume":"6","author":"Lalani","year":"2018","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.clgc.2018.07.003_bib34","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/j.clgc.2017.12.015","article-title":"Association between pretreatment neutrophil-to-lymphocyte ratio and outcome of patients with metastatic renal-cell carcinoma treated with nivolumab","volume":"16","author":"Bilen","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2018.07.003_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.lungcan.2017.07.024","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab","volume":"111","author":"Diem","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clgc.2018.07.003_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ebiom.2017.03.029","article-title":"Neutrophil to lymphocyte ratio is associated with outcome during ipilimumab treatment","volume":"18","author":"Cassidy","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clgc.2018.07.003_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.urolonc.2017.12.020","article-title":"Role of immunotherapy in bacillus Calmette-Gu\u00e9rin-unresponsive non-muscle invasive bladder cancer","volume":"36","author":"Mukherjee","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2018.07.003_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12254-018-0396-y","article-title":"PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients: dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer","volume":"11","author":"Resch","year":"2018","journal-title":"Memo"},{"key":"10.1016\/j.clgc.2018.07.003_bib39","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1464-410X.2010.09217.x","article-title":"International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy","volume":"105","author":"Shariat","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2018.07.003_bib40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrurol.2016.126","article-title":"The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder","volume":"13","author":"Mathieu","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib41","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrurol.2017.125","article-title":"Characteristics and clinical significance of histological variants of bladder cancer","volume":"14","author":"Moschini","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clgc.2018.07.003_bib42","first-page":"2048","article-title":"Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder","volume":"175","author":"Rogers","year":"2006","journal-title":"J\u00a0Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318301836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318301836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:31:02Z","timestamp":1761564662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767318301836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1558767318301836"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2018.07.003","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non\u2013muscle-invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}